News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Jun 18, 2024, 18:23

Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care

Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X:

“Cancer trial participation not associated with longer OS compared to routine care.

Motivation for patients:

  • Potential benefits other than OS eg structured care protocols.
  • To contribute to a better treatment for FUTURE patients.”

Matthias Guckenberger

Additional information.
Source: Matthias Guckenberger/X

 

cancer cancer trial Hannah Moyer Jonathan Kimmelman Karine Vigneault Matthias Guckenberger OncoDaily Oncology patient care Renata Iskander Salaheddin M. Mahmud University Hospital Zurich
Special Coverage
Voices
Aug 15, 2025, 21:03
Drew Moghanaki: Cautionary Lessons from Dr. Mammarappallil on Percutaneous MWA for Lung Tumors
Voices
Aug 15, 2025, 21:01
Oliver Bogler: The NIH Review Process Doesn’t Have to Be a Mystery - Learn How to Navigate Study Section
Voices
Aug 15, 2025, 20:42
Heloisa Soares: Huntsman Cancer Institute Theranostics Program is Expanding
Insight
Aug 15, 2025, 20:14
Guilherme Harada: Honored to Have Contributed to This Study
Insight
Aug 15, 2025, 19:54
Rahul Banerjee: Faster, More Accurate Detection of Multiple Myeloma Progression
Voices
Aug 15, 2025, 19:27
Michael Chuong: Exciting Developments in RT for Pancreatic Cancer
Voices
Aug 15, 2025, 16:15
Theodoros Teknos: Case Comprehensive Cancer Center Awarded $25.5M NCI Cancer Center Support Grant
Science
Aug 15, 2025, 16:10
Saheli Sadanand: Excited to Share a New Cancer Vaccine Study in Nature Medicine
Voices
Aug 15, 2025, 16:00
Amy C Moore Highlights Persistent Challenges in Lung Cancer Survival and Research
Voices
Aug 15, 2025, 15:57
David Heredia Highlighted New Research on Membrane Targets in RET+ NSCLC
Voices
Aug 15, 2025, 15:57
Stephen Liu: Proud to Co-chair The 2026 Texas Lung Cancer Conference with Dr. Tina Cascone
Voices
Aug 15, 2025, 15:57
Minhua Chu: KRAS G12D Inhibitor GFH375 Delivers Strong Responses in NSCLC